We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
19 hedge funds and large institutions have $688K invested in Atossa Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
293% more capital invested
Capital invested by funds: $175K → $688K (+$513K)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
58% more funds holding
Funds holding: 12 → 19 (+7)
0.01% more ownership
Funds ownership: 0.01% → 0.03% (+0.01%)
Holders
19
Holders Change
+7
Holders Change %
+58.33%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$156K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$93.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$86.8K |
| 4 |
Barclays
London,
United Kingdom
|
+$83.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.4K |
